About this episode
Technology investing goes far beyond hardware and consumer gadgets. This episode explores how the sector has evolved, focusing on the underlying “technology DNA” that now runs through industries from finance to healthcare. Jeremy Gleeson, manager of the Allianz Global Hi-Tech Growth fund, covers enterprise and consumer spending trends, the realities of AI investment and returns and the less glamorous but essential infrastructure powering innovation. We examine opportunities beyond the dominant mega-cap names, including mid-cap and Asian technology leaders, cybersecurity, networking and data infrastructure.What’s covered in this episode: What defines a “technology” company todayTechnology DNA vs traditional labelsEnterprise vs consumer tech spendingAI investment: promise and pitfallsSecond-order AI beneficiariesLife beyond the mega-cap tech giantsMid-cap and Asian tech opportunitiesCybersecurity as essential infrastructureValuations and bubble fearsThe next frontier: space technologyLearn more on fundcalibre.comPlease remember, we’ve been discussing individual companies to bring investing to life for you. It’s not a recommendation to buy or sell. The fund may or may not still hold these companies at the time of listening. Elite Ratings are based on FundCalibre’s research methodology and are the opinion of FundCalibre’s research team only.
